This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chanvorachote, P. Articles by Rojanasakul, Y. Search for Related Content PubMed PubMed Citation Articles by Chanvorachote, P. Articles by Rojanasakul, Y.

Nitric Oxide Regulates Cell Sensitivity to Cisplatin-Induced Apoptosis through S-Nitrosylation and Inhibition of Bcl-2 Ubiquitination

¹ Department of Pharmaceutical Sciences and ² Mary Babb Randolph Cancer Center, West Virginia University; ³ Pathology and Physiology Research Branch, National Institute for Occupational Safety and Health, Morgantown, West Virginia; and ⁴ Pharmaceutical Technology (International) Program, Chulalongkorn University, Bangkok, Thailand

Requests for reprints: Yon Rojanasakul, West Virginia University, Morgantown, WV 26506. E-mail: yrojanasakul{at}hsc.wvu.edu or Ubonthip Nimmannit, Chulalongkorn University, Bangkok 10330, Thailand. Phone: 304-293-1476; E-mail: Ubonthip.N{at}Chula.ac.th.

Cisplatin is a potent cytotoxic agent commonly used for the treatment of solid tumors. However, tumor cell–acquired resistance to cisplatin-induced apoptosis is a major limitation for efficient therapy, as frequently observed in human lung cancer. Nitric oxide (NO) is a key regulator of apoptosis, but its role in cisplatin-induced cell death and the underlying mechanism are largely unknown. Previous studies indicate increased NO synthase activity and elevated NO production in lung carcinomas, which correlate with the incidence of chemotherapeutic resistance. Here, we show that NO impairs the apoptotic function of cells and increases their resistance to cisplatin-induced cell death in human lung carcinoma H-460 cells. The NO donors sodium nitroprusside and dipropylenetriamine NONOate were able to inhibit cisplatin-induced cell death, whereas the NO inhibitors aminoguanidine and 2-(4-carboxyphenyl)-4,4,5,5-tetra-methylimidazoline-1-oxyl-3-oxide had opposite effect. Cisplatin resistance in H-460 cells is mediated by Bcl-2, and NO up-regulates its expression by preventing the degradation of Bcl-2 via ubiquitin-proteasome pathway. Cisplatin-induced generation of reactive oxygen species causes dephosphorylation and degradation of Bcl-2. In contrast, generation of NO has no effect on Bcl-2 phosphorylation but induces S-nitrosylation of the protein, which inhibits its ubiquitination and subsequent proteasomal degradation. These findings indicate a novel pathway for NO regulation of Bcl-2, which provides a key mechanism for cisplatin resistance and its potential modulation for improved cancer chemotherapy. (Cancer Res 2006; 66(12): 6365-60)

This article has been cited by other articles:

				P. Chanvorachote, U. Nimmannit, Y. Lu, S. Talbott, B.-H. Jiang, and Y. Rojanasakul Nitric Oxide Regulates Lung Carcinoma Cell Anoikis through Inhibition of Ubiquitin-Proteasomal Degradation of Caveolin-1 J. Biol. Chem., October 9, 2009; 284(41): 28476 - 28484. [Abstract] [Full Text] [PDF]

				R. Meller The Role of the Ubiquitin Proteasome System in Ischemia and Ischemic Tolerance Neuroscientist, June 1, 2009; 15(3): 243 - 260. [Abstract] [PDF]

				N. Azad, A. K. V. Iyer, A. Manosroi, L. Wang, and Y. Rojanasakul Superoxide-mediated proteasomal degradation of Bcl-2 determines cell susceptibility to Cr(VI)-induced apoptosis Carcinogenesis, August 1, 2008; 29(8): 1538 - 1545. [Abstract] [Full Text] [PDF]

				L. Kongkaneramit, N. Sarisuta, N. Azad, Y. Lu, A. K. V. Iyer, L. Wang, and Y. Rojanasakul Dependence of Reactive Oxygen Species and FLICE Inhibitory Protein on Lipofectamine-Induced Apoptosis in Human Lung Epithelial Cells J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 969 - 977. [Abstract] [Full Text] [PDF]

				L. Wang, P. Chanvorachote, D. Toledo, C. Stehlik, R. R. Mercer, V. Castranova, and Y. Rojanasakul Peroxide Is a Key Mediator of Bcl-2 Down-Regulation and Apoptosis Induction by Cisplatin in Human Lung Cancer Cells Mol. Pharmacol., January 1, 2008; 73(1): 119 - 127. [Abstract] [Full Text] [PDF]

				C. Perrotta, L. Bizzozero, S. Falcone, P. Rovere-Querini, A. Prinetti, E. H. Schuchman, S. Sonnino, A. A. Manfredi, and E. Clementi Nitric Oxide Boosts Chemoimmunotherapy via Inhibition of Acid Sphingomyelinase in a Mouse Model of Melanoma Cancer Res., August 15, 2007; 67(16): 7559 - 7564. [Abstract] [Full Text] [PDF]

				W.-Z. Ying, H.-G. Zhang, and P. W. Sanders EGF Receptor Activity Modulates Apoptosis Induced by Inhibition of the Proteasome of Vascular Smooth Muscle Cells J. Am. Soc. Nephrol., January 1, 2007; 18(1): 131 - 142. [Abstract] [Full Text] [PDF]

				J. Moungjaroen, U. Nimmannit, P. S. Callery, L. Wang, N. Azad, V. Lipipun, P. Chanvorachote, and Y. Rojanasakul Reactive Oxygen Species Mediate Caspase Activation and Apoptosis Induced by Lipoic Acid in Human Lung Epithelial Cancer Cells through Bcl-2 Down-Regulation J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1062 - 1069. [Abstract] [Full Text] [PDF]

				N. Azad, V. Vallyathan, L. Wang, V. Tantishaiyakul, C. Stehlik, S. S. Leonard, and Y. Rojanasakul S-Nitrosylation of Bcl-2 Inhibits Its Ubiquitin-Proteasomal Degradation: A NOVEL ANTIAPOPTOTIC MECHANISM THAT SUPPRESSES APOPTOSIS J. Biol. Chem., November 10, 2006; 281(45): 34124 - 34134. [Abstract] [Full Text] [PDF]